Mirador Capital Partners LP Lifted Gilead Sciences (GILD) Holding; Energy Transfer Partners LP (ETP) Sentiment Is 0.5

May 23, 2018 - By Linda Rogers

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Mirador Capital Partners Lp increased Gilead Sciences Inc (GILD) stake by 85.12% reported in 2017Q4 SEC filing. Mirador Capital Partners Lp acquired 4,984 shares as Gilead Sciences Inc (GILD)’s stock rose 1.93%. The Mirador Capital Partners Lp holds 10,839 shares with $777,000 value, up from 5,855 last quarter. Gilead Sciences Inc now has $88.34B valuation. The stock increased 0.16% or $0.1075 during the last trading session, reaching $67.9375. About 3.34M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 23, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Energy Transfer Partners LP (ETP) investors sentiment is 0.5 in 2017 Q4. It’s the same as in 2017Q3. The ratio is without change, as only 6 active investment managers increased or started new stock positions, while 12 trimmed and sold positions in Energy Transfer Partners LP. The active investment managers in our database reported: 1.44 million shares, down from 41.68 million shares in 2017Q3. Also, the number of active investment managers holding Energy Transfer Partners LP in top ten stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 4 Reduced: 8 Increased: 4 New Position: 2.

More important recent Energy Transfer Partners, L.P. (NYSE:ETP) news were published by: Seekingalpha.com which released: “Energy Transfer Partners: These 7.375% Fixed-To-Floating Units Started Trading On The NYSE” on May 02, 2018, also Seekingalpha.com published article titled: “Energy Transfer Partners LP (ETP) Q1 2018 Results – Earnings Call Transcript”, Seekingalpha.com published: “Energy Transfer Equity upped to Buy at BAML, as seen consolidation likely” on May 17, 2018. More interesting news about Energy Transfer Partners, L.P. (NYSE:ETP) was released by: Nasdaq.com and their article: “3 Dividend Stocks That Pay You More Than IBM Does” with publication date: May 22, 2018.

Analysts await Energy Transfer Partners, L.P. (NYSE:ETP) to report earnings on August, 14. They expect $0.25 earnings per share, up 725.00% or $0.29 from last year’s $-0.04 per share. ETP’s profit will be $291.32 million for 19.27 P/E if the $0.25 EPS becomes a reality. After $0.24 actual earnings per share reported by Energy Transfer Partners, L.P. for the previous quarter, Wall Street now forecasts 4.17% EPS growth.

Energy Transfer Partners, L.P. engages in the natural gas midstream, and intrastate transportation and storage businesses in the United States. The company has market cap of $22.46 billion. The companyÂ’s Intrastate Transportation and Storage segment transports natural gas from various natural gas producing areas, and through ET fuel system and HPL system. It has a 20.72 P/E ratio. This segment owns and operates approximately 7,900 miles of natural gas transportation pipelines and three natural gas storage facilities in Texas.

The stock 0.01% or $0 during the last trading session, reaching $19.27. It is down 32.38% since May 23, 2017 and is downtrending. It has underperformed by 43.93% the S&P500.

Old West Investment Management Llc holds 0.92% of its portfolio in Energy Transfer Partners, L.P. for 89,855 shares. Novare Capital Management Llc owns 272,386 shares or 0.83% of their US portfolio. Moreover, Cohen Capital Management Inc. has 0.64% invested in the company for 153,799 shares. The Texas-based Adams Asset Advisors Llc has invested 0.62% in the stock. Grassi Investment Management, a California-based fund reported 186,515 shares.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Bizjournals.com which released: “He helped Gilead score billions from HIV, hepatitis C drugs — now he’s building a cancer fighter” on May 23, 2018, also Seekingalpha.com with their article: “Gilead: Where’s The Next Catalyst?” published on May 18, 2018, Nasdaq.com published: “3 Biotechs on the FDA’s Naughty List That Should Be on Investors’ Buy Lists” on May 22, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: I’m Thankful That I Sold” published on May 07, 2018 as well as 247Wallst.com‘s news article titled: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” with publication date: May 02, 2018.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by BMO Capital Markets on Tuesday, January 2. Leerink Swann maintained the stock with “Market Perform” rating in Wednesday, February 7 report. The stock has “Hold” rating by BMO Capital Markets on Friday, July 21. The firm has “Outperform” rating by Oppenheimer given on Tuesday, October 20. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, May 26. Wells Fargo maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, December 4 with “Market Perform” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Outperform” rating by BMO Capital Markets on Wednesday, November 2. Leerink Swann maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, February 22 with “Hold” rating. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, October 18 with “Buy” rating. The firm earned “Buy” rating on Wednesday, February 3 by Standpoint Research.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It worsened, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Northwestern Mutual Wealth Management accumulated 85,575 shares. Argent accumulated 34,851 shares or 0.67% of the stock. Mngmt Professionals invested 0.01% in Gilead Sciences, Inc. (NASDAQ:GILD). Murphy Cap Mgmt, New Jersey-based fund reported 7,204 shares. 17,082 were accumulated by Manchester Mgmt Limited Liability. E&G LP owns 26,097 shares. Barclays Public Ltd Company holds 0.16% in Gilead Sciences, Inc. (NASDAQ:GILD) or 2.74M shares. 10,765 were reported by Carnegie Capital Asset Mgmt Lc. Moreover, Raab Moskowitz Asset Mngmt has 0.44% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Bridges Counsel Inc invested 0.31% in Gilead Sciences, Inc. (NASDAQ:GILD). Eagle Global Advisors Limited Com has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Northern Tru holds 0.3% or 16.70M shares. The New York-based Tower Rech Limited Liability Co (Trc) has invested 0.08% in Gilead Sciences, Inc. (NASDAQ:GILD). Augustine Asset Mngmt has 44,348 shares for 1.8% of their portfolio. Arizona State Retirement reported 330,962 shares.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: